 Fernando Kim
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 30 | 2018 | 395 | 5.800 |
Why?
| | Cryosurgery | 11 | 2023 | 50 | 4.150 |
Why?
| | Prostatic Neoplasms | 16 | 2023 | 913 | 2.560 |
Why?
| | Kidney Neoplasms | 13 | 2022 | 324 | 2.490 |
Why?
| | Nephrectomy | 13 | 2022 | 149 | 2.030 |
Why?
| | Carcinoma, Renal Cell | 8 | 2022 | 168 | 2.000 |
Why?
| | Minimally Invasive Surgical Procedures | 6 | 2015 | 154 | 1.520 |
Why?
| | Urologic Surgical Procedures | 8 | 2012 | 94 | 1.340 |
Why?
| | Prostatectomy | 9 | 2015 | 97 | 1.340 |
Why?
| | Robotics | 8 | 2022 | 76 | 1.090 |
Why?
| | Urology | 4 | 2015 | 46 | 1.040 |
Why?
| | Laparoscopes | 4 | 2014 | 10 | 1.030 |
Why?
| | Ergonomics | 3 | 2015 | 23 | 0.940 |
Why?
| | Sodium Chloride | 2 | 2015 | 133 | 0.920 |
Why?
| | Ureter | 2 | 2014 | 31 | 0.870 |
Why?
| | Ultrasonic Surgical Procedures | 2 | 2014 | 4 | 0.860 |
Why?
| | Ureteroscopy | 6 | 2016 | 16 | 0.850 |
Why?
| | Robotic Surgical Procedures | 4 | 2022 | 86 | 0.840 |
Why?
| | Dissection | 2 | 2014 | 51 | 0.820 |
Why?
| | Pelvis | 2 | 2015 | 89 | 0.800 |
Why?
| | Endoscopy | 3 | 2013 | 245 | 0.790 |
Why?
| | Treatment Outcome | 26 | 2023 | 9049 | 0.780 |
Why?
| | Lithotripsy, Laser | 4 | 2016 | 8 | 0.740 |
Why?
| | Urinary Calculi | 2 | 2014 | 11 | 0.730 |
Why?
| | Lithotripsy | 3 | 2013 | 40 | 0.700 |
Why?
| | Salvage Therapy | 2 | 2018 | 127 | 0.680 |
Why?
| | Prostate | 4 | 2014 | 157 | 0.640 |
Why?
| | Kidney Calculi | 4 | 2014 | 30 | 0.630 |
Why?
| | Prostatic Hyperplasia | 2 | 2015 | 38 | 0.600 |
Why?
| | Equipment Failure Analysis | 2 | 2015 | 132 | 0.590 |
Why?
| | Ultrasonics | 2 | 2014 | 46 | 0.570 |
Why?
| | Humans | 76 | 2023 | 114045 | 0.540 |
Why?
| | Urethra | 3 | 2013 | 48 | 0.530 |
Why?
| | Ureteral Calculi | 3 | 2014 | 13 | 0.530 |
Why?
| | Kidney | 6 | 2019 | 1182 | 0.500 |
Why?
| | Lasers, Solid-State | 2 | 2014 | 21 | 0.490 |
Why?
| | Male | 41 | 2023 | 55396 | 0.480 |
Why?
| | Cryotherapy | 1 | 2015 | 14 | 0.480 |
Why?
| | Musculoskeletal Pain | 1 | 2015 | 23 | 0.470 |
Why?
| | Urinary Tract | 3 | 2023 | 35 | 0.470 |
Why?
| | Equipment Design | 6 | 2014 | 503 | 0.470 |
Why?
| | Consumer Behavior | 1 | 2015 | 65 | 0.460 |
Why?
| | Laser Therapy | 1 | 2015 | 99 | 0.460 |
Why?
| | Biopsy | 3 | 2015 | 1024 | 0.460 |
Why?
| | Operative Time | 4 | 2015 | 106 | 0.450 |
Why?
| | Aged | 24 | 2016 | 18969 | 0.440 |
Why?
| | Intraoperative Complications | 2 | 2013 | 120 | 0.440 |
Why?
| | Carcinoid Tumor | 2 | 2018 | 23 | 0.440 |
Why?
| | Video-Assisted Surgery | 1 | 2013 | 4 | 0.440 |
Why?
| | Penile Neoplasms | 1 | 2013 | 7 | 0.430 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2018 | 850 | 0.430 |
Why?
| | Prostate-Specific Antigen | 5 | 2023 | 150 | 0.430 |
Why?
| | Ureterostomy | 1 | 2013 | 3 | 0.420 |
Why?
| | Cystostomy | 1 | 2013 | 8 | 0.420 |
Why?
| | Hot Temperature | 1 | 2014 | 301 | 0.410 |
Why?
| | Middle Aged | 27 | 2016 | 26605 | 0.410 |
Why?
| | Retrospective Studies | 21 | 2023 | 12521 | 0.400 |
Why?
| | Lymph Node Excision | 1 | 2013 | 140 | 0.400 |
Why?
| | Patient Preference | 1 | 2014 | 164 | 0.400 |
Why?
| | Hysterectomy | 1 | 2013 | 105 | 0.390 |
Why?
| | Diabetic Nephropathies | 1 | 2015 | 234 | 0.390 |
Why?
| | Surgical Equipment | 1 | 2011 | 13 | 0.380 |
Why?
| | Drug Delivery Systems | 1 | 2013 | 295 | 0.360 |
Why?
| | Pelvic Bones | 1 | 2013 | 126 | 0.360 |
Why?
| | Suture Techniques | 2 | 2023 | 115 | 0.340 |
Why?
| | Wounds, Nonpenetrating | 2 | 2013 | 249 | 0.330 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 486 | 0.330 |
Why?
| | Fournier Gangrene | 1 | 2009 | 1 | 0.320 |
Why?
| | Hydrotherapy | 1 | 2009 | 8 | 0.320 |
Why?
| | Hydrocarbons | 1 | 2009 | 29 | 0.320 |
Why?
| | Scrotum | 1 | 2009 | 23 | 0.310 |
Why?
| | Penis | 1 | 2009 | 37 | 0.310 |
Why?
| | Debridement | 1 | 2009 | 71 | 0.310 |
Why?
| | Clinical Medicine | 1 | 2008 | 18 | 0.310 |
Why?
| | Tomography, X-Ray Computed | 8 | 2016 | 2272 | 0.300 |
Why?
| | Mediastinal Diseases | 1 | 2007 | 9 | 0.290 |
Why?
| | Adult | 23 | 2016 | 30375 | 0.290 |
Why?
| | Reproducibility of Results | 4 | 2018 | 2764 | 0.280 |
Why?
| | Abdominal Injuries | 1 | 2008 | 107 | 0.280 |
Why?
| | Neoplasm Grading | 4 | 2016 | 241 | 0.270 |
Why?
| | Quality of Life | 2 | 2023 | 2343 | 0.260 |
Why?
| | Urinary Bladder | 1 | 2008 | 161 | 0.260 |
Why?
| | Body Mass Index | 1 | 2013 | 1957 | 0.260 |
Why?
| | Urinary Incontinence | 4 | 2014 | 56 | 0.260 |
Why?
| | Sarcoidosis | 1 | 2007 | 133 | 0.250 |
Why?
| | Vas Deferens | 1 | 2005 | 16 | 0.250 |
Why?
| | Blood Loss, Surgical | 3 | 2015 | 82 | 0.250 |
Why?
| | Hernia, Inguinal | 1 | 2005 | 28 | 0.240 |
Why?
| | Ureterolithiasis | 2 | 2016 | 2 | 0.240 |
Why?
| | Postoperative Complications | 7 | 2014 | 2122 | 0.220 |
Why?
| | Amino Acid Transport Systems, Basic | 1 | 2023 | 3 | 0.220 |
Why?
| | Cystinuria | 1 | 2023 | 3 | 0.220 |
Why?
| | Nephrostomy, Percutaneous | 3 | 2014 | 9 | 0.220 |
Why?
| | Incisional Hernia | 1 | 2023 | 1 | 0.220 |
Why?
| | Testicular Diseases | 1 | 2003 | 6 | 0.220 |
Why?
| | Cystine | 1 | 2023 | 14 | 0.220 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2023 | 8 | 0.220 |
Why?
| | Feasibility Studies | 4 | 2013 | 735 | 0.210 |
Why?
| | Digestive System Surgical Procedures | 1 | 2023 | 91 | 0.210 |
Why?
| | Solitary Kidney | 1 | 2022 | 6 | 0.210 |
Why?
| | Apoptosis | 1 | 2011 | 2349 | 0.210 |
Why?
| | Aged, 80 and over | 7 | 2018 | 6306 | 0.210 |
Why?
| | Sheep | 2 | 2014 | 761 | 0.200 |
Why?
| | Surgeons | 2 | 2023 | 236 | 0.200 |
Why?
| | Risk Factors | 8 | 2015 | 8614 | 0.190 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2018 | 196 | 0.190 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2087 | 0.190 |
Why?
| | Obesity | 1 | 2013 | 2505 | 0.180 |
Why?
| | Tissue Donors | 1 | 2003 | 314 | 0.180 |
Why?
| | Cattle | 2 | 2014 | 918 | 0.180 |
Why?
| | Urologic Diseases | 2 | 2011 | 35 | 0.180 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 22 | 0.180 |
Why?
| | Marital Status | 2 | 2014 | 41 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2022 | 287 | 0.160 |
Why?
| | Female | 20 | 2018 | 59324 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 1204 | 0.150 |
Why?
| | Guidelines as Topic | 1 | 2019 | 241 | 0.150 |
Why?
| | Kidney Transplantation | 1 | 2003 | 538 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2022 | 4392 | 0.140 |
Why?
| | Hematoma | 1 | 2016 | 50 | 0.130 |
Why?
| | Spectrum Analysis | 1 | 2016 | 83 | 0.130 |
Why?
| | Injury Severity Score | 2 | 2019 | 472 | 0.130 |
Why?
| | Transurethral Resection of Prostate | 1 | 2015 | 3 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 74 | 0.130 |
Why?
| | Adrenalectomy | 1 | 2015 | 59 | 0.130 |
Why?
| | Volatilization | 1 | 2015 | 49 | 0.130 |
Why?
| | Survival Analysis | 2 | 2017 | 1206 | 0.120 |
Why?
| | Erectile Dysfunction | 2 | 2013 | 38 | 0.120 |
Why?
| | Animals | 8 | 2015 | 31565 | 0.120 |
Why?
| | Length of Stay | 2 | 2017 | 957 | 0.120 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2015 | 48 | 0.120 |
Why?
| | Adrenocortical Carcinoma | 1 | 2015 | 47 | 0.120 |
Why?
| | Renal Veins | 1 | 2014 | 10 | 0.120 |
Why?
| | Organ Sparing Treatments | 1 | 2014 | 31 | 0.120 |
Why?
| | Incidental Findings | 1 | 2015 | 70 | 0.120 |
Why?
| | Watchful Waiting | 1 | 2015 | 54 | 0.120 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2014 | 20 | 0.120 |
Why?
| | Intraoperative Period | 1 | 2014 | 51 | 0.120 |
Why?
| | Mesentery | 1 | 2014 | 41 | 0.120 |
Why?
| | Male Urogenital Diseases | 1 | 2014 | 2 | 0.120 |
Why?
| | Female Urogenital Diseases | 1 | 2014 | 5 | 0.120 |
Why?
| | Wyoming | 1 | 2014 | 17 | 0.110 |
Why?
| | Holmium | 1 | 2014 | 1 | 0.110 |
Why?
| | Yttrium | 1 | 2014 | 5 | 0.110 |
Why?
| | Rectal Fistula | 1 | 2014 | 21 | 0.110 |
Why?
| | Hemostatic Techniques | 1 | 2014 | 37 | 0.110 |
Why?
| | Aluminum | 1 | 2014 | 33 | 0.110 |
Why?
| | Equipment Failure | 1 | 2014 | 107 | 0.110 |
Why?
| | Inguinal Canal | 1 | 2013 | 7 | 0.110 |
Why?
| | Abdominal Wall | 1 | 2013 | 24 | 0.110 |
Why?
| | Cystadenoma, Mucinous | 1 | 2013 | 13 | 0.110 |
Why?
| | Autopsy | 1 | 2013 | 83 | 0.110 |
Why?
| | Urinary Catheterization | 1 | 2013 | 22 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 637 | 0.110 |
Why?
| | Nephrolithiasis | 1 | 2013 | 10 | 0.110 |
Why?
| | Remission Induction | 1 | 2013 | 233 | 0.110 |
Why?
| | Regression Analysis | 2 | 2013 | 945 | 0.110 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2012 | 11 | 0.100 |
Why?
| | Adenoma | 1 | 2014 | 187 | 0.100 |
Why?
| | Image-Guided Biopsy | 1 | 2012 | 30 | 0.100 |
Why?
| | Materials Testing | 1 | 2014 | 337 | 0.100 |
Why?
| | Brazil | 1 | 2012 | 89 | 0.100 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2012 | 26 | 0.100 |
Why?
| | Wounds, Penetrating | 1 | 2013 | 68 | 0.100 |
Why?
| | Particle Size | 1 | 2013 | 317 | 0.100 |
Why?
| | Computer Systems | 1 | 2012 | 46 | 0.100 |
Why?
| | Insurance, Health | 1 | 2014 | 243 | 0.100 |
Why?
| | Models, Animal | 2 | 2011 | 340 | 0.100 |
Why?
| | Logistic Models | 2 | 2014 | 1829 | 0.100 |
Why?
| | Constriction, Pathologic | 1 | 2013 | 207 | 0.100 |
Why?
| | Temperature | 1 | 2014 | 564 | 0.100 |
Why?
| | Reference Values | 1 | 2013 | 739 | 0.100 |
Why?
| | Microsurgery | 1 | 2012 | 58 | 0.100 |
Why?
| | Neoplasm Metastasis | 1 | 2013 | 521 | 0.100 |
Why?
| | Urologic Neoplasms | 1 | 2011 | 24 | 0.090 |
Why?
| | Sus scrofa | 1 | 2011 | 45 | 0.090 |
Why?
| | Trauma Centers | 1 | 2013 | 347 | 0.090 |
Why?
| | Necrosis | 1 | 2011 | 209 | 0.090 |
Why?
| | Models, Theoretical | 1 | 2014 | 513 | 0.090 |
Why?
| | Esthetics | 1 | 2011 | 37 | 0.090 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 61 | 0.090 |
Why?
| | Terminology as Topic | 2 | 2009 | 186 | 0.090 |
Why?
| | Surgicenters | 1 | 2010 | 6 | 0.090 |
Why?
| | Cicatrix | 1 | 2011 | 49 | 0.090 |
Why?
| | Learning Curve | 1 | 2011 | 63 | 0.090 |
Why?
| | Prone Position | 1 | 2010 | 27 | 0.090 |
Why?
| | Supine Position | 1 | 2010 | 32 | 0.090 |
Why?
| | Blood Vessels | 1 | 2011 | 179 | 0.090 |
Why?
| | Risk Assessment | 3 | 2015 | 2958 | 0.080 |
Why?
| | Psychomotor Performance | 1 | 2012 | 281 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2537 | 0.080 |
Why?
| | Computer Simulation | 1 | 2013 | 873 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2014 | 3498 | 0.080 |
Why?
| | Forecasting | 1 | 2011 | 331 | 0.080 |
Why?
| | Valproic Acid | 1 | 2009 | 43 | 0.080 |
Why?
| | Lacerations | 1 | 2009 | 27 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2012 | 349 | 0.080 |
Why?
| | Soft Tissue Injuries | 1 | 2009 | 31 | 0.080 |
Why?
| | Skin Transplantation | 1 | 2009 | 57 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 2 | 2006 | 1175 | 0.080 |
Why?
| | Rectal Diseases | 1 | 2008 | 17 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2014 | 787 | 0.080 |
Why?
| | Fractures, Bone | 1 | 2013 | 367 | 0.080 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2008 | 18 | 0.080 |
Why?
| | Kidney Medulla | 1 | 2008 | 29 | 0.080 |
Why?
| | Intestinal Perforation | 1 | 2008 | 39 | 0.080 |
Why?
| | Urinary Bladder Diseases | 1 | 2008 | 18 | 0.080 |
Why?
| | Kidney Tubules, Collecting | 1 | 2008 | 25 | 0.070 |
Why?
| | Rupture | 1 | 2008 | 96 | 0.070 |
Why?
| | Time Factors | 3 | 2014 | 6077 | 0.070 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 1875 | 0.070 |
Why?
| | Cohort Studies | 4 | 2014 | 4883 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2010 | 405 | 0.070 |
Why?
| | Endometriosis | 1 | 2008 | 40 | 0.070 |
Why?
| | Radionuclide Imaging | 1 | 2007 | 115 | 0.070 |
Why?
| | Cell Separation | 1 | 2008 | 290 | 0.070 |
Why?
| | Europe | 3 | 2014 | 332 | 0.070 |
Why?
| | Pyrroles | 1 | 2008 | 181 | 0.070 |
Why?
| | Age Factors | 1 | 2014 | 2885 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 845 | 0.070 |
Why?
| | Wound Healing | 1 | 2009 | 254 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 3039 | 0.070 |
Why?
| | Neurilemmoma | 1 | 2006 | 19 | 0.070 |
Why?
| | Societies, Medical | 1 | 2009 | 655 | 0.060 |
Why?
| | Indoles | 1 | 2008 | 300 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1791 | 0.060 |
Why?
| | Vulnerable Populations | 1 | 2006 | 129 | 0.060 |
Why?
| | Cell Culture Techniques | 1 | 2008 | 341 | 0.060 |
Why?
| | Ultrasonography | 2 | 2012 | 635 | 0.060 |
Why?
| | Treatment Failure | 1 | 2006 | 330 | 0.060 |
Why?
| | Remote Consultation | 1 | 2004 | 42 | 0.060 |
Why?
| | Urinary Incontinence, Stress | 1 | 2003 | 12 | 0.050 |
Why?
| | Epithelioid Cells | 1 | 2003 | 8 | 0.050 |
Why?
| | Angiomyolipoma | 1 | 2003 | 17 | 0.050 |
Why?
| | Iatrogenic Disease | 1 | 2023 | 47 | 0.050 |
Why?
| | Hematuria | 2 | 2018 | 7 | 0.050 |
Why?
| | Postoperative Care | 1 | 2004 | 223 | 0.050 |
Why?
| | Laparotomy | 1 | 2023 | 101 | 0.050 |
Why?
| | Organ Size | 2 | 2014 | 434 | 0.050 |
Why?
| | Microwaves | 1 | 2022 | 31 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2008 | 1032 | 0.050 |
Why?
| | Genetics, Population | 1 | 2023 | 187 | 0.050 |
Why?
| | Gene Frequency | 1 | 2023 | 476 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2009 | 2173 | 0.050 |
Why?
| | Prognosis | 3 | 2016 | 3315 | 0.050 |
Why?
| | Reoperation | 1 | 2023 | 513 | 0.050 |
Why?
| | Health Care Surveys | 2 | 2018 | 541 | 0.050 |
Why?
| | Patient Satisfaction | 1 | 2004 | 571 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 296 | 0.040 |
Why?
| | Rectum | 2 | 2012 | 151 | 0.040 |
Why?
| | Incidence | 3 | 2012 | 2314 | 0.040 |
Why?
| | Cystoscopy | 1 | 2018 | 16 | 0.040 |
Why?
| | General Surgery | 1 | 2019 | 125 | 0.040 |
Why?
| | Patient Positioning | 1 | 2018 | 41 | 0.040 |
Why?
| | Pain | 1 | 2003 | 701 | 0.040 |
Why?
| | Prospective Studies | 4 | 2012 | 6195 | 0.040 |
Why?
| | Triage | 1 | 2019 | 197 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2014 | 1422 | 0.030 |
Why?
| | Radiography | 2 | 2010 | 803 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2016 | 34 | 0.030 |
Why?
| | United States | 5 | 2014 | 12137 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2016 | 180 | 0.030 |
Why?
| | Drainage | 1 | 2016 | 145 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1015 | 0.030 |
Why?
| | Age Distribution | 2 | 2005 | 341 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2003 | 1471 | 0.030 |
Why?
| | Pain Measurement | 1 | 2016 | 441 | 0.030 |
Why?
| | Clinical Competence | 2 | 2011 | 882 | 0.030 |
Why?
| | Freezing | 1 | 2014 | 84 | 0.030 |
Why?
| | Thiazides | 1 | 2013 | 1 | 0.030 |
Why?
| | Lasers | 1 | 2014 | 121 | 0.030 |
Why?
| | Citrates | 1 | 2013 | 42 | 0.030 |
Why?
| | Mutation | 1 | 2023 | 3338 | 0.030 |
Why?
| | Allopurinol | 1 | 2013 | 53 | 0.030 |
Why?
| | Xanthine Oxidase | 1 | 2013 | 71 | 0.030 |
Why?
| | Kallikreins | 1 | 2012 | 28 | 0.030 |
Why?
| | Adolescent | 2 | 2008 | 17800 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1690 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2012 | 86 | 0.020 |
Why?
| | Matched-Pair Analysis | 1 | 2011 | 33 | 0.020 |
Why?
| | Germany | 1 | 2011 | 84 | 0.020 |
Why?
| | Asia | 1 | 2011 | 53 | 0.020 |
Why?
| | South America | 1 | 2011 | 52 | 0.020 |
Why?
| | Equipment Reuse | 1 | 2011 | 11 | 0.020 |
Why?
| | Posture | 1 | 2011 | 152 | 0.020 |
Why?
| | Registries | 2 | 2009 | 1764 | 0.020 |
Why?
| | Occupational Diseases | 1 | 2011 | 128 | 0.020 |
Why?
| | Swine | 1 | 2012 | 687 | 0.020 |
Why?
| | Organizational Objectives | 1 | 2009 | 66 | 0.020 |
Why?
| | Risk | 1 | 2012 | 810 | 0.020 |
Why?
| | Equipment and Supplies | 1 | 2009 | 38 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1624 | 0.020 |
Why?
| | Ovarian Cysts | 1 | 2008 | 8 | 0.020 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2008 | 8 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2009 | 193 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 544 | 0.020 |
Why?
| | Cystectomy | 1 | 2008 | 32 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 169 | 0.020 |
Why?
| | Culture Media | 1 | 2008 | 155 | 0.020 |
Why?
| | Patient Selection | 1 | 2011 | 629 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2009 | 246 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2008 | 164 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 221 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 4595 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1143 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 541 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2009 | 1162 | 0.020 |
Why?
| | Health Surveys | 1 | 2006 | 441 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1014 | 0.010 |
Why?
| | Cell Movement | 1 | 2009 | 863 | 0.010 |
Why?
| | Brachytherapy | 1 | 2005 | 100 | 0.010 |
Why?
| | SEER Program | 1 | 2005 | 195 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 336 | 0.010 |
Why?
| | Biomedical Research | 1 | 2009 | 582 | 0.010 |
Why?
| | Health Services Research | 1 | 2006 | 373 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2005 | 492 | 0.010 |
Why?
| | Colorado | 1 | 2012 | 4090 | 0.010 |
Why?
| | Gene Expression | 1 | 2008 | 1417 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1331 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2008 | 946 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 2700 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2005 | 1080 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 925 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2004 | 459 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2182 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 10444 | 0.010 |
Why?
| | Rats | 1 | 2003 | 4913 | 0.010 |
Why?
|
|
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|